Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
10/2010
10/13/2010CN101152170B Capsule containing pseudoephedrine and method for preparing the same
10/13/2010CN101125153B Acanthopanax root granule and its preparation method
10/13/2010CN101107249B Purine derivatives acting as a2a receptor agonists
10/13/2010CN101019869B Medicine composition of alprostadil and Chuanhuning/Yanhuning liposome and its preparation
10/12/2010US7812160 G-protein-coupled chemoattractant receptor, expressed on T helper cells antagonists such as [4-(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)-5-pyrimidinyl]acetic acid;, used for the treatment of allergic diseases, inflammatory diseases, eosinophil- and basophil-related diseases
10/12/2010US7812038 such as vascular cell adhesion molecules and fibronectins, administered for the treatment of asthma, multiple sclerosis or inflammatory bowel diseases in mammals; (3S)-3-{[({1-[(2-chlorophenyl)methyl]-4-hydroxy-2-oxo-1,2-dihydro-3quinolinyl}amino)carbonyl]amino}-3-(4-methylphenyl)propanoic acid
10/12/2010US7811988 A lipid mixture for synthetic surfactants comprising >40% by weight of 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and >10% of polyunsaturated phospholipids; treatment of surfactant deficiencies like infant respiratory distress syndrome (RDS); rheology; low surface tension; fast spreading
10/12/2010US7811816 Isolated CD8 +T lymphocytes specifically cytotoxic for a disease causing target cell
10/12/2010US7811590 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system
10/12/2010US7811573 Targetting dendritic cells, endothelial cells, and macrophages which express integrins, to induce maturation
10/12/2010CA2533919C Therapeutic agent for chronic obstructive pulmonary disease and method for treating chronic obstructive pulmonary disease using the same
10/12/2010CA2445512C A method for treating or preventing a functional vitamin b12 deficiency in an individual and medical compositions for use in said method
10/12/2010CA2427352C Glycerophosphoinositol derivatives as modulators of cytosolic phospholipase
10/12/2010CA2425420C Administration of resveratrol to treat inflammatory respiratory disorders
10/12/2010CA2419552C Substituted pyrazoles
10/12/2010CA2416899C Method of treating symptoms of common cold, allergic rhinitis and infections relating to the respiratory tract
10/12/2010CA2329751C Substituted porphyrins
10/07/2010WO2010115032A1 Pulmonary and nasal delivery of serum amyloid p
10/07/2010WO2010114476A1 Novel derivatives of steroidal[3,2-c]pyrazole compounds with glucocorticoid activity
10/07/2010WO2010114473A1 Novel steroidal[3,2-c]pyrazol derivatives with glucocorticoid activity
10/07/2010WO2010114472A1 Pharmaceutical composition comprising a steroidal[3,2-c]pyrazole derivative and a second pharmaceutically active compound
10/07/2010WO2010114471A1 Novel amide derivatives of steroidal[3,2-c]pyrazole compounds with glucocorticoid activity
10/07/2010WO2010114106A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010114105A1 Monoclonal antibody capable of binding to ad2 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010WO2010113952A1 Muscarinic receptor antagonist
10/07/2010WO2010113834A1 Pyrimidine compound
10/07/2010WO2010113022A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010WO2010112936A1 P38map kinase inhibitor
10/07/2010US20100256240 Prostacyclin derivatives
10/07/2010US20100256237 Potentiating the effect of compound comprising nitric oxide
10/07/2010US20100256213 Tosylate Salt Of Trans-N-Isobutyl-3-Fluoro-3- [3-Fluoro-4-(Pyrrolidin-1-YL-Methyl)-Phenyl] Cyclobut Anecarboxamide
10/07/2010US20100256185 Crystalline forms of a biphenyl compound
10/07/2010US20100256184 Pharmaceutical composition and administrations thereof
10/07/2010US20100256178 Super-oxide dismutase mimetics
10/07/2010US20100256174 External preparation composition comprising fatty acid-based ionic liquid as active ingredient
10/07/2010US20100256166 Novel Hydantoin Derivatives as Metalloproteinase Inhibitors
10/07/2010US20100256161 Fibrinogen receptor antagonists and their use
10/07/2010US20100256157 Method of treatment
10/07/2010US20100256141 Novel bis-azaindole derivatives, preparation and pharmaceutical use thereof as kinase inhibitors
10/07/2010US20100256120 Amide derivatives
10/07/2010US20100256119 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
10/07/2010US20100256118 Novel adenine compound and use thereof
10/07/2010US20100256105 Novel compounds
10/07/2010US20100256104 Novel amide compounds
10/07/2010US20100256103 Novel compounds
10/07/2010US20100256101 Novel bronchodilating alpha, beta-unsaturated isoquinoline amides
10/07/2010US20100256085 Toll-Like Receptor Agonist Regulation of VEGF-Induced Tissue Responses
10/07/2010US20100256056 Analogues of exendin-4 and exendin-3
10/07/2010US20100256043 Use of a peptide as a therapeutic agent
10/07/2010US20100255537 Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
10/07/2010US20100255102 Sterilization of dispersions of nanoparticulate active agents with gamma radiation
10/07/2010US20100255083 Controlled-release pharmaceutical formulation and process for its preparation
10/07/2010US20100255066 Orally-administered agent
10/07/2010US20100255063 Compressed Chewing Gum Tablet
10/07/2010US20100255056 Fibronectin Type III Domain Based Scaffold Compositions, Methods And Uses
10/07/2010US20100255033 Non-toxic double mutant forms of pertussis toxin as adjuvants
10/07/2010US20100255013 Glycoprotein compositions
10/07/2010US20100254993 Human monoclonal antibodies against human il-4
10/07/2010US20100254992 Anti-mcp-1 antibodies, compositions, methods and uses
10/07/2010US20100254990 Anti-ngf antibodies for the treatment of various disorders
10/07/2010US20100254979 Humanized PAI-1 Antibodies and Uses Thereof
10/07/2010US20100254973 Materials and Methods for Diagnosis of Asthma
10/07/2010US20100254972 Methods for selecting protease resistant polypeptides
10/07/2010US20100254939 Graft copolymers as drug delivery systems
10/07/2010DE102009016553A1 Sulfonamid- und Sulfoximin-substituierte Diaryldihydropyrimidinone und ihre Verwendung Sulfonamide and sulfoximine-substituted Diaryldihydropyrimidinone and their use
10/07/2010CA2757615A1 Plasminogen activator inhibitor-1 inhibitor
10/07/2010CA2757500A1 Pulmonary and nasal delivery of serum amyloid p
10/07/2010CA2757424A1 Novel derivatives of steroidal[3,2-c]pyrazole compounds with glucocorticoid activity
10/07/2010CA2757423A1 Novel amide derivatives of steroidal[3,2-c]pyrazole compounds with glucocorticoid activity
10/07/2010CA2757188A1 Pyrimidine compound
10/07/2010CA2756926A1 Pharmaceutical composition comprising a steroidal[3,2-c]pyrazole derivative and a second pharmaceutically active compound
10/07/2010CA2756889A1 Monoclonal antibody capable of binding to specific discontinuous epitope occurring in ad1 region of human cytomegalovirus gb glycoprotein, and antigen-binding fragment thereof
10/07/2010CA2754609A1 P38map kinase inhibitor
10/06/2010EP2236605A1 Human anti- 9 integrin antibody
10/06/2010EP2236518A2 Humaneered anti-factor B antibody
10/06/2010EP2236152A1 Albumin fusion proteins
10/06/2010EP2236149A1 Medicinal composition
10/06/2010EP2235037A1 Steroid derivatives acting as glucocorticosteroid receptor agonists
10/06/2010EP2235018A1 Pharmaceutically acceptable salts of methyl (3-{ ýý3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl¨(3- morpholin-4-ylpropyl) amino¨methyl }phenyl) acetate and their use in therapy
10/06/2010EP2235016A1 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
10/06/2010EP2235015A2 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof
10/06/2010EP2235014A2 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/06/2010EP2234989A1 Tetrazole-substituted arylamide derivatives and their use as p2x3 and/or p2x2/3 purinergic receptor antagonists
10/06/2010EP2234985A1 4-(4-cyano-2-thioaryl)dihydropyrimidinones and use thereof
10/06/2010EP2234626A1 Method and means for producing bronchorelaxation
10/06/2010EP2234613A1 P-menthawe-3-carboxylic acid esters to treat airways diseases
10/06/2010EP2234597A1 Enhancing photostabilization of oxymetazoline
10/06/2010EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
10/06/2010CN1769286B Compound and pharmaceutical composition for treating nasal oversecreation and chronic obstructive pulmonary disease
10/06/2010CN1681508B Novel inhibitors of kinases
10/06/2010CN1646684B Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
10/06/2010CN1626076B Andrographolide drop pills and preparation method
10/06/2010CN1606444B Inhibitors of human phosphatidyl-inositol 3-kinase delta
10/06/2010CN1520300B Dihydro-triterpenes in treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
10/06/2010CN101851238A Substituted 8-heteroaryl xanthines
10/06/2010CN101851191A Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment
10/06/2010CN101850105A Cefuroxime sodium composite medicine
10/06/2010CN101850103A Clindamycin phosphate composite medicine
10/06/2010CN101850093A Medicinal composition for treating hyperplasia of mammary glands
10/06/2010CN101850083A Chinese medicament for treating asthma
1 ... 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 ... 878